Skip to content

Effects of different modes of repetitive transcranial magnetic stimulation on Upper Extremity Rehabilitation in Stroke Patients

Effects of different modes of repetitive transcranial magnetic stimulation on Upper Extremity Rehabilitation in Stroke Patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088143
Enrollment
Unknown
Registered
2024-08-12
Start date
2024-08-12
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Motor dysfunction of upper limbs in stroke patients with hemiplegia

Interventions

ITBS group:iTBS stimulation
high frequency rTMS Group:high frequency rTMS stimulation
sham stimulation group:In the sham stimulation

Sponsors

Department of Rehabilitation Medicine, the Second Affiliated Hospital of Xi 'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. In accordance with the diagnostic criteria of major cerebrovascular diseases in China 2019, patients with symptomatic ischemic or hemorrhagic stroke for the first time were confirmed by MRI or CT. 2. Course of disease =1 month and =12 months . 3. The lesions were located in unilateral cerebral cortex, basal ganglia or multiple regions, and had motor dysfunction of upper extremity. 4. Age 18-85 years;. 5. The patient is stable and conscious, and can be evaluated for treatment. 6. Patients or their family members understand the relevant issues after voluntary participation in clinical trials and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe cognitive and communication impairment, inability to understand and cooperate with treatment and evaluation. 2. Stroke is a progressive or secondary cerebral hemorrhage and other conditions of instability; 3. Previous history of seizures or family history of epilepsy ; 4. Accompanied by heart, lung, liver, kidney and other important organ dysfunction or failure; 5. Internal artificial pacemaker or metal implants ; 6. There were other causes of upper extremity motor dysfunction before the onset of the disease.

Design outcomes

Primary

MeasureTime frame
Wolf Motor Function Test, WMFT;

Secondary

MeasureTime frame
the Upper Extremity Section of the Fugl-Meyer Assessment, FMA-UE;the Upper Extremity Section of the Modified Ashworth Scale, MASUE;Modified Barthel Index, MBI;Stroke-specific Quality of Life scale, SS-QOL;Motion Evoked Potential,MEP;

Countries

China

Contacts

Public ContactZhang qiaojun

Department of Rehabilitation Medicine, the Second Affiliated Hospital of Xi 'an Jiaotong University

zhangqj@mail.xjtu.edu.cn+86 29 8767 9570

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026